西山 博之(ニシヤマ ヒロユキ)
- 論文
- Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer
Nitta Satoshi; Kawai Koji; Nagumo Yoshiyuki; Kandori Shu...
Japanese journal of clinical oncology, 2019-07 - 尿道ブジー後にBCG膀胱内注入療法を施行し, 発熱, 肝機能障害, 間質性肺炎を認めた1例
Nitta Satoshi; Sakka Shotaro; Endo Tsuyoshi; Komine Mana...
泌尿器科紀要, 2017-10 - Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
Nitta Satoshi; Tsutsumi Masakazu; Sakka Shotaro; Endo Ts...
PROSTATE INTERNATIONAL, 2019-09 - Predictors of venous thromboembolism development before and during chemotherapy for advanced germ cell tumor
Nitta Satoshi; Kawai Koji; Kimura Tomokazu; Kawahara ...
Japanese journal of clinical oncology/50(3)/pp.338-343, 2020-03 - Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan
Ikeda Atsushi; Kojima Takahiro; Kawai Koji; Hinotsu Shir...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/25(6)/pp.1163-1169, 2020-03 - Co-Morbidity Among Childhood Cancer Survivors at "The Comprehensive Medical Checkup for CCS at University of Tsukuba Hospital"
Fukushima Hiroko; Suzuki Ryoko; Yamaki Yuni; Hosaka Sho; ...
PEDIATRIC BLOOD & CANCER/66(5:SI)/pp.S90-S90, 2019-12 - 膀胱癌に対するAtezolizumab併用放射線療法：第Ⅱ相医師主導多施設共同治験プロトコル
関野 雄太; 石川 仁; 木村友和; 東治人; 吉田謙; 影山幸雄; 齋藤吉弘; 都築豊徳; 西山博之
日本放射線腫瘍学会第32回学術大会報文集/pp.276-267, 2019-11 - The impact of histologic variants of urothelial carcinoma on clinical outcomes following trimodal bladder-preserving therapy.
Nagumo Yoshiyuki; Kandori Shuya; Kimura Tomokazu; Kawahar...
JOURNAL OF CLINICAL ONCOLOGY/37(7::S), 2019-03 - Keynote-676: Phase 3 study of bacillus calmette-guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) non muscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction.
Kamat Ashish M.; Shore Neal D.; Hahn Noah M.; Alanee Sha...
JOURNAL OF CLINICAL ONCOLOGY/37(7::S), 2019-03 - The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A).
Inokuchi Junichi; Kuroiwa Kentaro; Nishiyama Hiroyuki; Ko...
JOURNAL OF CLINICAL ONCOLOGY/37(7::S), 2019-03 - A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.
Hahn Noah M.; Chang Sam S.; Meng Maxwell; Shore Neal D.; ...
JOURNAL OF CLINICAL ONCOLOGY/37(7::S), 2019-03 - A phase Ill, randomized, open-label, multicenter, global study of durvalumab and bacillus calmette-guerin (BCG) versus BCG alone in high-risk, BCG-naive non-muscle-invasive bladder cancer (NMIBC) patients (POTOMAC).
De Santis Maria; Abdrashitov Ramil; Hegele Axel; Kolb Ma...
JOURNAL OF CLINICAL ONCOLOGY/37(7::S), 2019-03 - Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG).
Balar Arjun Vasant; Kulkarni Girish S.; Uchio Edward M.; ...
JOURNAL OF CLINICAL ONCOLOGY/37(7::S), 2019-03 - Biomarker analyses of ramucirumab in patients with platinum refractory urothelial cancer from RANGE, a global, randomized, double-blind, phase III study
Van der Heijden M.; Powles T.; Petrylak D.; de Wit R.; Ch...
ANNALS OF ONCOLOGY/30(5), 2019-10 - Health-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
de Wit R.; Kulkarni G. S.; Uchio E.; Boormans J. L.; Roum...
ANNALS OF ONCOLOGY/30(5), 2019-10 - Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey
Choo Seol Ho; Nishiyama Hiroyuki; Kitamura Hiroshi; Ch...
International journal of urology : official journal of the Japanese Urological Association/26(12)/pp.1121-1127, 2019-12 - Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial
Nishiyama Hiroyuki; Yamamoto Yoshiaki; Sassa Naoto; Ni...
International journal of clinical oncology/25(1)/pp.165-174, 2020-01 - Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Petrylak Daniel P; de Wit Ronald; Chi Kim N; Drakaki ...
The Lancet. Oncology/21(1)/pp.105-120, 2020-01 - Clinicopathological features of malignant urachal tumor: A hospital-based cancer registry data in Japan
Nagumo Yoshiyuki; Kojima Takahiro; Shiga Masanobu; Kojo ...
International journal of urology : official journal of the Japanese Urological Association/27(2)/pp.157-162, 2019-12 - Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence
Ikeda Atsushi; Nosato Hirokazu; Kochi Yuta; Kojima Takah...
Journal of endourology/34(3)/pp.352-358, 2019-12 - A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin (G plus C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA).
Powles Thomas; Meeks Joshua J.; Galsky Matt D.; Van der H...
JOURNAL OF CLINICAL ONCOLOGY/37(15::S), 2019-05 - Bacillus Calmette-Guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) that is persistent or recurrent following BCG induction: Phase III KEYNOTE-676 study.
Kamat Ashish M.; Shore Neal D.; Hahn Noah M.; Alanee Sha...
JOURNAL OF CLINICAL ONCOLOGY/37(15::S), 2019-05 - Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG): Updated follow-up from KEYNOTE-057.
De Wit Ronald; Kulkarni Girish S.; Uchio Edward M.; Krieg...
JOURNAL OF CLINICAL ONCOLOGY/37(15::S), 2019-05 - Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
Nitta Satoshi; Tsutsumi Masakazu; Sakka Shotaro; Endo Ts...
PROSTATE INTERNATIONAL/7(3)/pp.114-118, 2019-09 - A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma
Nagumo Yoshiyuki; Kojima Takahiro; Shiga Masanobu; Kan...
International journal of clinical oncology/25(2)/pp.354-361, 2020-02 - さらに表示...
- Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer